Pfizer's Hair-Loss Oral Treatment Litfulo Gets FDA Approval
June 23 2023 - 5:37PM
Dow Jones News
By Sabela Ojea
Pfizer said Friday the Food and Drug Administration has approved
Litfulo, its oral treatment for alopecia.
The healthcare company said Litfulo can treat patients aged 12
years and older, becoming the only medication approved by the FDA
for adolescents with severe alopecia areata.
Write to Sabela Ojea at sabela.ojea@wsj.com
(END) Dow Jones Newswires
June 23, 2023 18:22 ET (22:22 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Jan 2025 to Feb 2025
Pfizer (NYSE:PFE)
Historical Stock Chart
From Feb 2024 to Feb 2025
